New test aims to personalize colon cancer treatment
Disease control
Not yet recruiting
This trial aims to see if a specific biomarker test can help doctors choose the best first treatment for patients with advanced colon cancer that started on the right side. It will test if patients with a 'high' biomarker result do better when a targeted drug (cetuximab) is added…
Phase: PHASE4 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC